{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:27:11Z","timestamp":1791977231011,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofcardiovascularct.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Computed Tomography"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jcct.2019.12.033","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T19:33:44Z","timestamp":1579289624000},"page":"343-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of 5-lipoxygenase inhibitor, VIA-2291 (Atreleuton), on epicardial fat volume in patients with recent acute coronary syndrome"],"prefix":"10.1016","volume":"14","author":[{"given":"Shone O.","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben J.","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Kinninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9963","key":"10.1016\/j.jcct.2019.12.033_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"10.1016\/j.jcct.2019.12.033_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molmed.2017.02.004","article-title":"Epigenetics of atherosclerosis: emerging mechanisms and methods","volume":"23","author":"Khyzha","year":"2017","journal-title":"Trends Mol Med"},{"issue":"21","key":"10.1016\/j.jcct.2019.12.033_bib3","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/eurheartj\/ehx143","article-title":"Atherosclerotic plaque vulnerability in the statin era","volume":"38","author":"Nilsson","year":"2017","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.jcct.2019.12.033_bib4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcct.2019.12.033_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13805","article-title":"Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials","author":"Catapano","year":"2017","journal-title":"Br J Pharmacol. March"},{"issue":"9","key":"10.1016\/j.jcct.2019.12.033_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11886-017-0896-0","article-title":"Where does inflammation fit?","volume":"19","author":"Biasucci","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jcct.2019.12.033_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cca.2017.02.017","article-title":"IL-37 increased in patients with acute coronary syndrome and associated with a worse clinical outcome after ST-segment elevation acute myocardial infarction","volume":"468","author":"Liu","year":"2017","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"3","key":"10.1016\/j.jcct.2019.12.033_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCIMAGING.110.937169","article-title":"Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome","volume":"3","author":"Tardif","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.jcct.2019.12.033_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa025079","article-title":"Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis","volume":"350","author":"Dwyer","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jcct.2019.12.033_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00439-008-0489-5","article-title":"Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease","volume":"123","author":"Assimes","year":"2008","journal-title":"Hum Genet"},{"issue":"1","key":"10.1016\/j.jcct.2019.12.033_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1056\/NEJMp038190","article-title":"From asthma to atherosclerosis--5-lipoxygenase, leukotrienes, and inflammation","volume":"350","author":"De Caterina","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jcct.2019.12.033_bib12","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1073\/pnas.242716099","article-title":"Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis","volume":"100","author":"Spanbroek","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.jcct.2019.12.033_bib13","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1161\/01.ATV.0000172632.96987.2d","article-title":"Association between 5-lipoxygenase expression and plaque instability in humans","volume":"25","author":"Cipollone","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.jcct.2019.12.033_bib14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","article-title":"Adipose tissue, inflammation, and cardiovascular disease","volume":"96","author":"Berg","year":"2005","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jcct.2019.12.033_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s001250050868","article-title":"Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals","volume":"41","author":"Eriksson","year":"1998","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.jcct.2019.12.033_bib16","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/oby.2008.278","article-title":"The association of pericardial fat with calcified coronary plaque","volume":"16","author":"Ding","year":"2008","journal-title":"Obes Silver Spring Md"},{"issue":"7","key":"10.1016\/j.jcct.2019.12.033_bib17","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/dc10-0245","article-title":"Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors: the Jackson heart study","volume":"33","author":"Liu","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.jcct.2019.12.033_bib18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/eurheartj\/ehn573","article-title":"Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study","volume":"30","author":"Mahabadi","year":"2009","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jcct.2019.12.033_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/clc.22646","article-title":"Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study","volume":"40","author":"Matsumoto","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jcct.2019.12.033_bib20","author":"Gaztanaga"},{"issue":"11 Supplement","key":"10.1016\/j.jcct.2019.12.033_bib21","doi-asserted-by":"crossref","first-page":"A1686","DOI":"10.1016\/S0735-1097(18)32227-7","article-title":"Reliability of cardiac fat volumes measured by non-contrast coronary calcium computed tomography using a semi-automated cardiac fat analysis software","volume":"71","author":"Jayawardena","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jcct.2019.12.033_bib22","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.ijcard.2013.01.182","article-title":"Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis","volume":"168","author":"Ahmadi","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.jcct.2019.12.033_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.atherosclerosis.2013.03.003","article-title":"Relation of vascular stiffness with epicardial and pericardial adipose tissues, and coronary atherosclerosis","volume":"229","author":"Choi","year":"2013","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jcct.2019.12.033_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.atherosclerosis.2014.01.038","article-title":"Prognostic value of coronary artery calcium and epicardial adipose tissue assessed by non-contrast cardiac computed tomography","volume":"233","author":"Kunita","year":"2014","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jcct.2019.12.033_bib25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2014.09.037","article-title":"Increased epicardial adipose tissue is associated with coronary artery disease and major adverse cardiovascular events","volume":"237","author":"Hajsadeghi","year":"2014","journal-title":"Atherosclerosis"}],"container-title":["Journal of Cardiovascular Computed Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934592519302102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934592519302102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:01:31Z","timestamp":1761832891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934592519302102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1934592519302102"],"URL":"https:\/\/doi.org\/10.1016\/j.jcct.2019.12.033","relation":{},"ISSN":["1934-5925"],"issn-type":[{"value":"1934-5925","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of 5-lipoxygenase inhibitor, VIA-2291 (Atreleuton), on epicardial fat volume in patients with recent acute coronary syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Computed Tomography","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcct.2019.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}